Effect of age at the time of vaccination on antibody titers and feedlot performance in beef calves

Authors:
  • DSDouglas L. Step
    Douglas L. Step
  • MPMark E. Payton
    Mark E. Payton
  • JRJeffrey B. Richards
    Jeffrey B. Richards
  • LMLawrence F. McTague
    Lawrence F. McTague
  • ACAnthony W. Confer
    Anthony W. Confer
  • BCBilly J. Cook
    Billy J. Cook
  • SIShan H. Ingram
    Shan H. Ingram
  • JWJohn C. Wright
    John C. Wright
Publisher website
Google Scholar
Abstract
Objective—To compare antibody responses, feedlot morbidity and mortality rates, feedlot performance, and carcass value for calves vaccinated with 1 of 2 vaccination strategies and for unvaccinated control calves. Design—Randomized controlled clinical trial. Animals—451 beef steers and heifers. Procedures—Calves were vaccinated with a modified-live infectious bovine rhinotracheitis virus (IBRV), bovine viral diarrhea virus types 1 (BVDV1) and 2 (BVDV2), parainfluenza type 3 virus, and bovine respiratory syncytial virus vaccine and Mannheimia haemolytica and Pasteurella multocida bacterin-toxoid at approximately 67 and 190 days of age (group 1; n = 151) or at approximately 167 and 190 days of age (group 2; 150) or were not vaccinated (control; 150). Serum antibody titers were measured at approximately 2, 67, 167, 190, and 232 days of age. Morbidity and mortality rates, feedlot performance, and carcass value were recorded for 361 calves shipped to feedlots. Results—Percentages of calves seroconverting to IBRV, BVDV1, and BVDV2 were significantly higher for groups 1 and 2 than for the control group. Mean treatment costs were significantly lower for vaccinated than for control calves, and mean mortality rate was significantly higher for control calves than for group 1 calves. Feedlot performance and carcass value did not vary significantly among groups. Conclusions and Clinical Relevance—Results suggested that vaccination of beef calves with a 5-antigen modified-live virus vaccine at 67 and 190 days of age was as effective in terms of immunologic responses as was vaccination at 167 and 190 days of age.

This publication has 12 references indexed in Scilit: